Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Galapagos NV ADR
GXECurrent price
24.2 EUR
-0.52 EUR (-2.10%)
Last closed
26.44 USD
Company
www.glpg.com
ISIN
US36315X1019
Sector
Healthcare
Industry
Biotechnology
Exchange
Stuttgart Exchange
Capitalization
1 962 233 856 USD
Yield for 12 month
-27.44 %
1Y
3Y
5Y
10Y
15Y
GXE
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium. Address: Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
31.14 USDP/E ratio
55.6731Dividend Yield
–Current Year
+259 282 453 USD
Last Year
+546 504 472 USD
Current Quarter
+84 226 454 USD
Last Quarter
+84 226 454 USD
Current Year
+259 256 495 USD
Last Year
+533 439 978 USD
Current Quarter
+66 318 612 USD
Last Quarter
+66 318 613 USD
Key Figures GXE
1 year
3 years
5 years
10 years
EBITDA
-101 320 000 USD
Operating Margin TTM
PE Ratio
55.6731
Return On Assets TTM
-1.76 %
PEG Ratio
–
Return On Equity TTM
1.15 %
Wall Street Target Price
31.14 USD
Revenue TTM
261 402 000 USD
Book Value
44.16 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
29.7 %
Dividend Yield
–
Gross Profit TTM
4 818 000 USD
Earnings per share
0.52 USD
Diluted Eps TTM
0.52 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
74.8 %
Profit Margin
108.11 %
Dividend Analytics GXE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GXE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GXE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
55.6731
Forward PE
166.6667
Enterprise Value Revenue
1.1836
Price Sales TTM
7.5066
Enterprise Value EBITDA
-31.4982
Price Book MRQ
0.6081
Financials GXE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GXE
For 52 weeks
24.16 USD
42.46 USD
50 Day MA
28.87 USD
Shares Short Prior Month
1 513 170
200 Day MA
30.35 USD
Short Ratio
14.21
Shares Short
1 516 067
Short Percent
3.08 %
BeatStart